The landscape of dementia diagnosis has evolved drastically with the advent of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. Whilst these technological advances characterize impressive progress in understanding neurodegenerative health conditions, https://lilliani329kvf0.blog-eye.com/profile